1. Home
  2. LIDR vs SYBX Comparison

LIDR vs SYBX Comparison

Compare LIDR & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • SYBX
  • Stock Information
  • Founded
  • LIDR 2013
  • SYBX N/A
  • Country
  • LIDR United States
  • SYBX United States
  • Employees
  • LIDR N/A
  • SYBX N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIDR Consumer Discretionary
  • SYBX Health Care
  • Exchange
  • LIDR Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • LIDR 14.8M
  • SYBX 13.6M
  • IPO Year
  • LIDR N/A
  • SYBX N/A
  • Fundamental
  • Price
  • LIDR $0.92
  • SYBX $1.26
  • Analyst Decision
  • LIDR Hold
  • SYBX
  • Analyst Count
  • LIDR 1
  • SYBX 0
  • Target Price
  • LIDR N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • LIDR 577.6K
  • SYBX 8.1K
  • Earning Date
  • LIDR 08-04-2025
  • SYBX 08-07-2025
  • Dividend Yield
  • LIDR N/A
  • SYBX N/A
  • EPS Growth
  • LIDR N/A
  • SYBX N/A
  • EPS
  • LIDR N/A
  • SYBX 0.21
  • Revenue
  • LIDR $246,000.00
  • SYBX N/A
  • Revenue This Year
  • LIDR $2,677.23
  • SYBX N/A
  • Revenue Next Year
  • LIDR $409.09
  • SYBX N/A
  • P/E Ratio
  • LIDR N/A
  • SYBX $5.79
  • Revenue Growth
  • LIDR N/A
  • SYBX N/A
  • 52 Week Low
  • LIDR $0.49
  • SYBX $0.90
  • 52 Week High
  • LIDR $4.30
  • SYBX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 65.47
  • SYBX 52.81
  • Support Level
  • LIDR $0.71
  • SYBX $1.17
  • Resistance Level
  • LIDR $0.88
  • SYBX $1.27
  • Average True Range (ATR)
  • LIDR 0.09
  • SYBX 0.04
  • MACD
  • LIDR 0.00
  • SYBX -0.01
  • Stochastic Oscillator
  • LIDR 89.21
  • SYBX 40.00

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: